Laboratori Fundació Dau Pharmadox Healthcare Ltd. Pharmathen International S.A. Pharmathen S.A.

Poland

All drugs from this manufacturer

  • DARUNAVIR ACCORD

    The medicinal product is used in the treatment of human immunodeficiency virus (HIV) infection in adults and children over 3 years of age and weighing more than 15 kg, who have previously been treated with other antiretroviral drugs.

    Dosage form: tablets, film-coated

    Active substance Dosage
    darunavir 150 mg

    ATC: J05AE10

  • The medicinal product is used in the treatment of human immunodeficiency virus (HIV) infections in adults and children over 3 years of age and weighing more than 15 kg, who have previously been treated with other antiretroviral drugs.

    Dosage form: tablets, film-coated

    Active substance Dosage
    darunavir 300 mg

    ATC: J05AE10

  • The medicinal product is used in the treatment of human immunodeficiency virus (HIV) infection in adults and children over 3 years of age (weighing more than 40 kg). It helps to reduce the amount of virus in the body and supports the immune system.

    Dosage form: tablets, film-coated

    Active substance Dosage
    darunavir 400 mg

    ATC: J05AE10

  • The medicinal product is used in the treatment of human immunodeficiency virus (HIV) infection in adults and children over 3 years of age and weighing more than 15 kg, who have previously been treated with other antiretroviral drugs.

    Dosage form: tablets, film-coated

    Active substance Dosage
    darunavir 600 mg

    ATC: J05AE10

  • The medicinal product is used in the treatment of human immunodeficiency virus (HIV) infection in adults and children over 3 years of age and weighing more than 40 kg.

    Dosage form: tablets, film-coated

    Active substance Dosage
    darunavir 800 mg

    ATC: J05AE10